You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Eylea

Showing 1 - 25 of 293
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Macular Degeneration (AMD) Post-marketing Surveillance in Japan

Completed
  • Macular Degeneration
  • Aflibercept(Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Japan
    (unnamed)
Jan 9, 2023

Eylea in Babies Born Too Early Who HaveCondition of Eye Where

Not yet recruiting
  • Retinopathy of Prematurity
  • +2 more
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, Japan
    Many locations
Jan 20, 2023

Chorioretinal Vascular Disease Trial (ABP 938, Aflibercept)

Not yet recruiting
  • Chorioretinal Vascular Disease
  • (no location specified)
Jan 20, 2023

Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)

Not yet recruiting
  • Diabetic Macular Edema (DME)
  • Neovascular Age-Related Macular Degeneration (nAMD)
  • aflibercept 8 mg PFS
  • (no location specified)
Aug 3, 2023

Aflibercept Injection in Japanese Neovascular Glaucoma (NVG)

Recruiting
  • Neovascular Glaucoma
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, Japan
    Many locations
Aug 17, 2022

CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea

Active, not recruiting
  • AMD
  • Exudative Macular Degeneration
    • Bordeaux, France
    • +4 more
    Dec 2, 2022

    Wet Age-related Macular Degeneration Trial in Beijing (Aflibercept)

    Completed
    • Wet Age-related Macular Degeneration
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Apr 19, 2022

    g Medical Records to Learn More About Treat-and-extend With

    Completed
    • Neovascular Age-related Macular Degeneration
    • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
    • Multiple Locations, Belgium
      Many Locations
    Jun 9, 2022

    Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in Tehran (Aflibercept (CinnaGen Co, Iran),

    Completed
    • Age-Related Macular Degeneration
    • Neovascular Age-related Macular Degeneration
    • Aflibercept (CinnaGen Co, Iran)
    • Aflibercept (Regeneron, USA)
    • Tehran, Iran, Islamic Republic of
      Farabi Hospital
    Oct 16, 2022

    Wet Age-related Macular Degeneration Trial (SCB-420, Aflibercept)

    Withdrawn
    • Wet Age-related Macular Degeneration
    • (no location specified)
    Apr 12, 2022

    Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)

    Recruiting
    • Diabetic Macular Edema
    • Beijing, Beijing, China
      Beijing tongren hospital affliated to capital medical university
    Apr 5, 2022

    Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)

    Completed
    • Diabetic Macular Edema
    • Beijing, Beijing, China
      Beijing tongren hospital affliated to capital medical university
    Apr 5, 2022

    Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML

    Withdrawn
    • Wet Macular Degeneration
    • Aflibercept 40 MG/ML [Eylea]
    • +2 more
    • Prague, Czechia
      Department of Ophthalmology, Faculty hospital Kralovske Vinohrad
    Aug 7, 2022

    Polypoidal Choroidal Vasculopathy Trial in Singapore (Aflibercept + reduced fluence photodynamic therapy (RF-PDT), Aflibercept +

    Recruiting
    • Polypoidal Choroidal Vasculopathy
    • Aflibercept + reduced fluence photodynamic therapy (RF-PDT)
    • Aflibercept + sham reduced fluence photodynamic therapy (RF-PDT)
    • Singapore, Singapore
    • +2 more
    Nov 14, 2022

    Diabetic Macular Edema, Diabetic Retinopathy Trial (4D-150 IVT, Aflibercept IVT)

    Not yet recruiting
    • Diabetic Macular Edema
    • Diabetic Retinopathy
    • 4D-150 IVT
    • Aflibercept IVT
    • (no location specified)
    Jun 26, 2023

    Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

    Recruiting
    • Metastatic Uveal Melanoma
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 2, 2023

    Exudative Age-related Macular Degeneration Trial in United States (RBM-007 Injectable Solution, Aflibercept, Sham)

    Completed
    • Exudative Age-related Macular Degeneration
    • RBM-007 Injectable Solution
    • +2 more
    • Phoenix, Arizona
    • +7 more
    Feb 5, 2022

    Chorioretinal Vascular Disease Trial in Houston, The Woodlands (Intravitreal Aflibercept Injection (IAI))

    Completed
    Has Results
    • Chorioretinal Vascular Disease
    • Intravitreal Aflibercept Injection (IAI)
    • Houston, Texas
    • +1 more
    Aug 18, 2021

    naïve Age-related Macular Degeneration of Neovascular Type and

    Completed
    • Age-related Macular Degeneration
    • Data extraction from medical files
    • Brussels, Belgium
      CHU Brugmann
    Mar 7, 2022

    Macular Degeneration Trial (Zimura, Avastin, Lucentis)

    Completed
    • Macular Degeneration
    • (no location specified)
    Oct 4, 2022

    Neovascular Age-related Macular Degeneration Trial in Graz (Aflibercept 40 MG/ML, Faricimab 120 MG/ML)

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • Aflibercept 40 MG/ML
    • Faricimab 120 MG/ML
    • Graz, Styria, Austria
      Department of Ophthalmolgy, Medical University Graz
    Jul 3, 2023

    Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • Phoenix, Arizona
      Retinal Research Institute, LLC
    Jun 4, 2023

    Use of Aflibercept Injections Into Eye for Treatment of Eye

    Recruiting
    • Retinal Disease
    • Aflibercept (BAY86-5321, Eylea)
    • Multiple Locations, Mexico
      Many locations
    Aug 22, 2022

    Wet Age-related Macular Degeneration Trial in Beijing (RC28-E, Aflibercept)

    Recruiting
    • Wet Age-related Macular Degeneration
    • Beijing, Beijing, China
      Beijing Hospital
    Feb 3, 2023

    rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

    Completed
    • Age Related Macular Degeneration
    • Bern, Switzerland
    • +1 more
    Nov 28, 2022